CI Investments Inc’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,081
Closed -$98K 1299
2025
Q1
$98K Sell
1,081
-5
-0.5% -$560 ﹤0.01% 918
2024
Q4
$124K Sell
1,086
-305
-22% -$34.8K ﹤0.01% 881
2024
Q3
$165K Buy
1,391
+11
+0.8% +$1.01K ﹤0.01% 717
2024
Q2
$111K Buy
1,380
+405
+42% +$37K ﹤0.01% 781
2024
Q1
$90K Buy
975
+1
+0.1% +$96 ﹤0.01% 918
2023
Q4
$103K Sell
974
-62
-6% -$6.25K ﹤0.01% 825
2023
Q3
$113K Sell
1,036
-30
-3% -$3.32K ﹤0.01% 804
2023
Q2
$115K Buy
1,066
+311
+41% +$35K ﹤0.01% 752
2023
Q1
$94K Sell
755
-10
-1% -$1.37K ﹤0.01% 756
2022
Q4
$115K Buy
765
+645
+538% +$99.3K ﹤0.01% 707
2022
Q3
$16K Sell
120
-8
-6% -$1.22K ﹤0.01% 1069
2022
Q2
$19K Buy
128
+2
+2% +$306 ﹤0.01% 978
2022
Q1
$21K Buy
+126
New +$21.2K ﹤0.01% 1047

Other funds holding BNTX

CI Investments Inc's BNTX Position: Q2 2025 in Review

CI Investments Inc sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 1,081 shares — an estimated $98K sold.

CI Investments Inc first reported a position in BNTX in Q1 2022 and held it in 13 quarters. The position peaked at $165K in Q3 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • CI Investments Inc reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,081 BioNTech shares in Q2 2025, an estimated $98K.
  • CI Investments Inc first reported a position in BioNTech in Q1 2022 and held it in 13 quarters.
  • CI Investments Inc's BioNTech position peaked at $165K in Q3 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.